Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters

A worldwide effort to counter the COVID-19 pandemic has resulted in hundreds of candidate vaccines moving through various stages of research and development, including several vaccines in phase 1, 2 and 3 clinical trials. A relatively small number of these vaccines have been evaluated in SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Brocato, Rebecca L., Kwilas, Steven A., Kim, Robert K., Zeng, Xiankun, Principe, Lucia M., Smith, Jeffrey M., Hooper, Jay W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835356/
https://www.ncbi.nlm.nih.gov/pubmed/33495468
http://dx.doi.org/10.1038/s41541-020-00279-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835356/
https://www.ncbi.nlm.nih.gov/pubmed/33495468
http://dx.doi.org/10.1038/s41541-020-00279-z

Ejemplares similares